Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8bad861dfb9e6f31b4b84aa9d3af22bf |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-765 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-765 |
filingDate |
2003-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9555848c3a485dca0099a88e0efeff26 |
publicationDate |
2005-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-1544212-A1 |
titleOfInvention |
Modified antiviral proteins with an increased negative charge |
abstract |
The invention relates to proteins and pharmaceutical preparations containing themnwhich are suitable for treating or curing viral infections including orthomyxovirusesnlike influenza, paramyxoviruses like parainfluenza, measles and immunodeficiencyndiseases such as, but not limited to, retrovirus infections, including AIDS and AIDS-relatedndiseases, and which also can be used to inhibit the fusion of virus-infectedncells with non-infected cells. |
priorityDate |
2003-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |